Immunome Inc (IMNM)

EBITDA Growth

-68.63%

Quarterly · Period ending:

IMNM logo

IMNM EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-68.63%
IMNM Quarterly EBITDA YoY % (-12.25% → -68.63%)
High-resolution chart · PNG

IMNM ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-68.6295%
-29.7502%
-25.6731%
-31.1689%
-29.2303%
-103.7347%
-304.6123%
-934.8169%
-511.5556%
-387.1907%
-80.6272%
50.3623%
38.6573%
64.2094%
2.6265%
-13.2957%
-73.8006%
-209.5136%
-103.1275%
9.2674%
-98.1612%
-49.3178%
-40.0442%
-219.1738%
-15.1351%
-12.2523%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.